Skip to content

Drug interactions

Vemurafenib + Vinblastine

Severity: Moderate

Vemurafenib and Vinblastine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vemurafenib inhibits P-glycoprotein in vitro and could raise vinblastine exposure. This may increase myelosuppression and neurotoxicity.

What this interaction means in plain words

Vemurafenib and Vinblastine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Vemurafenib belongs to Oncology; Vinblastine belongs to Oncology.

Evidence level: Low

Why it happens

Vemurafenib inhibits P-glycoprotein-mediated efflux of vinblastine.

What to do

Monitor blood counts and neurotoxicity, and reduce the vinblastine dose if toxicity appears.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Vemurafenib and Vinblastine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Vemurafenib with Vinblastine?

MediHelp rates the interaction as moderate. Vemurafenib and Vinblastine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Vemurafenib inhibits P-glycoprotein in vitro and could raise vinblastine exposure. This may increase myelosuppression and neurotoxicity.

How serious is the interaction between Vemurafenib and Vinblastine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and neurotoxicity, and reduce the vinblastine dose if toxicity appears.

What other medicines interact with Vinblastine?

MediHelp also lists interactions of Vinblastine with, for example, Adenovirus types 4 and 7 live, Apalutamide, Atazanavir. The full list is on the Vinblastine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in